In an industrial collaboration project, TU Wien has developed a medication that can alleviate or even completely eliminate the symptoms of celiac disease. It should be available as early as 2021.
Celiac disease is a fairly common disease, affecting one to two percent of the European population. It is expressed as a hypersensitivity to gluten, a protein found in cereals such as wheat, barley or rye.
Although efforts are already being made to treat celiac disease, the proposed drugs have an effect on the immune system. Possible side effects must therefore be examined very carefully. Although initial clinical studies are underway, they will not lead to a marketable product in the next few years.
For this reason, an entirely different approach has been pursued at TU Wien in collaboration with the industrial partner Sciotech Diagnostic Technologies GmbH. Instead of developing a drug that interferes with the immune system, TU Wien has created a simple medical product that directly attacks the gluten molecules to render them harmless. This makes the approval process much simpler, meaning that the product should be available in ordinary pharmacies as early as 2021.
Molecules like keys and locks
“Our bodies produce antibodies that fit intruding antigens precisely, like a key to a lock. This immune response makes these antigens harmless,” explains Professor Oliver Spadiut, head of the Integrated Bioprocess Development Research Group at TU Wien. “If a new antibody fragment is found and produced that docks to and blocks the invading gluten molecule without triggering the immune system, the symptoms of celiac disease can be suppressed.”
The aim of the research project was therefore to produce a complex of two such antibody fragments that envelop the gluten molecule at a molecular level, so that it can no longer have any further effects in the intestines.
To do this, certain bacteria have to be reprogrammed so that they produce exactly the desired antibody fragment. “The formation of such proteins in a bacterium is a highly complicated process,” explains Oliver Spadiut. “It can easily happen that the proteins are not folded exactly as we want.” Instead of the desired antibody fragments, so-called “inclusion bodies” are formed – small particles consisting of incorrectly folded proteins. A process therefore had to be developed to refold these inclusion bodies and to obtain the desired proteins from them.
Such processes, in which the folding of proteins is specifically altered, have not yet been studied in great detail and so they are not very efficient. “You have to precisely understand the chemical processes involved and intervene in a complicated way,” says Oliver Spadiut. “It has therefore taken a while, but we have now developed a process that can be easily reproduced, can be scaled up to industrial application and delivers a very good yield of the desired product”
In pharmacies soon
The project was supported by the industrial partner SCIOTEC Diagnostic Technologies GmbH, who will now bring the new medical product to the market. “It will be a preparation that celiac patients can take together with gluten-containing foods to alleviate coeliac symptoms,” explains Oliver Spadiut. “It remains to be seen whether the symptoms will disappear completely or will only be alleviated. The precise effects will probably vary from person to person.
Learn more: A new remedy for celiac disease
The Latest on: Celiac disease
[google_news title=”” keyword=”celiac disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Celiac disease
- Care Plan Your Doctor Would Usually Recommend For Celiac Diseaseon May 8, 2024 at 2:28 pm
Celiac disease is diagnosed by laboratory testing. The only way to manage this condition is to follow a strict gluten free diet. "William is digging deep," according to royal experts.
- 10 signs you might have celiac disease or gluten sensitivityon May 8, 2024 at 7:12 am
Ever heard of celiac disease or gluten sensitivity and wondered, “Could that be me?” Early detection and diagnosis can be game-changers. In this article, learn the top 10 signs that you might have ...
- Celiac Cruise adds more gluten-free river trips with AmaWaterwayson May 7, 2024 at 5:40 pm
The collaboration has already delivered cruises with 100% gluten-free vessels and experiences on the Danube and Seine. Celiac Cruise has now become AmaWaterways' exclusive partner for all gluten-free ...
- Jena DeMoss: Dietitian’s guide to gluten-freeon May 7, 2024 at 3:39 pm
You may have heard of gluten-free diets, but do you know if you need to follow them or what a gluten-free diet entails? As Hy-Vee registered dietitians, we help our clients navigate their dietary ...
- The Spectrum of Celiac Disease: Epidemiology, Clinical Aspects and Treatmenton May 5, 2024 at 5:00 pm
Celiac disease is a gluten-sensitive enteropathy that affects people of all ages worldwide. This disease has emerged as a major health-care problem, as advances in diagnostic and screening methods ...
- Understanding celiac diseaseon May 2, 2024 at 9:29 pm
But do you know that the ingestion of gluten protein, present in certain foods, can lead to celiac disease? Although the exact root cause is unknown, the consequence may necessitate a lifelong ...
- Top 6 Best Iron Supplement for Celiac Disease in 2024on April 25, 2024 at 5:00 pm
Nevertheless, people with celiac disease often battle with iron deficiency anemia, a condition that arises from the damage inflicted on their small intestine, thereby hampering the body’s ...
- Three Gluten-Free Friendly Restaurantson April 25, 2024 at 1:00 pm
And by far, the query that has appeared in my inbox with the greatest frequency has been about gluten-free dining. More than 2 million Americans have been diagnosed with Celiac — though researchers ...
- First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrientson April 24, 2024 at 6:00 am
The featured paper is entitled “Dynamics of Serologic Change to Gluten in Celiac Disease Patients” (doi.org/10.3390/nu15245083). The manuscript benefits from one of the largest databases of CeD ...
via Bing News